Find a Clinical Trial | Pfizer Clinical Trials

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

Male or Female

18+ years

44study location(s)

Recruiting

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Breast Cancer

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Liposarcoma, Prostate Cancer, Breast Neoplasms, Adenocarcinoma of Lung

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer

A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast

A Study of SGN-PDL1V in Advanced Solid Tumors

Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma, Ovarian Neoplasms, Melanoma, Triple Negative Breast Neoplasms, Gastric Cancer

a study to learn about the study medicine pf-07220060 together with letrozole compared to letrozole alone in women post menopause

breast cancer

female

18+ years

57study location(s)